Cited 20 times in
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.